|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Enlivex Therapeutics (NASDAQ: ENLV) through any online brokerage.
There are no as such competitors for Enlivex Therapeutics.
The latest price target for Enlivex Therapeutics (NASDAQ: ENLV) was reported by H.C. Wainwright on 2020-01-09. The analyst firm set a price target for 20.00 expecting ENLV to rise to within 12 months (a possible 99.20% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Enlivex Therapeutics (NASDAQ: ENLV) is $10.04 last updated Fri May 07 2021 20:00:02 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Enlivex Therapeutics.
There are no earnings for Enlivex Therapeutics
There is no upcoming split for Enlivex Therapeutics.